[1]Ԭǿ,¶­Ò»Æ½,ÕÅÓ±¡÷,µÈ.¸»ÑªÐ¡°åѪ½¬ÁªºÏ¹É¹ÇÍ·»µËÀÓú½ºÄÒÖÎÁƲ»Í¬Ãæ»ý¹É¹ÇÍ·»µËÀµÄÁÆЧ±È½Ï[J].ÖйúÖÐÒ½¹ÇÉË¿ÆÔÓÖ¾,2023,31(03):31-37.[doi:10.20085/j.cnki.issn1005-0205.230307]
¡¡YUAN Qiang,DONG Yiping,ZHANG Ying,et al.Comparison of Platelet-Rich Plasma Combined with Gugutou Huaisiyu Capsules on Necrosis of Femoral Head with Different Lesion Areas[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2023,31(03):31-37.[doi:10.20085/j.cnki.issn1005-0205.230307]
µã»÷¸´ÖÆ

¸»ÑªÐ¡°åѪ½¬ÁªºÏ¹É¹ÇÍ·»µËÀÓú½ºÄÒÖÎÁƲ»Í¬Ãæ»ý¹É¹ÇÍ·»µËÀµÄÁÆЧ±È½Ï()
·ÖÏíµ½£º

¡¶ÖйúÖÐÒ½¹ÇÉË¿ÆÔÓÖ¾¡·[ISSN:1005-0205/CN:42-1340/R]

¾í:
µÚ31¾í
ÆÚÊý:
2023Äê03ÆÚ
Ò³Âë:
31-37
À¸Ä¿:
ÁÙ´²Ñо¿
³ö°æÈÕÆÚ:
2023-03-15

ÎÄÕÂÐÅÏ¢/Info

Title:
Comparison of Platelet-Rich Plasma Combined with Gugutou Huaisiyu Capsules on Necrosis of Femoral Head with Different Lesion Areas
ÎÄÕ±àºÅ:
1005-0205(2023)03-0031-07
×÷Õß:
Ԭǿ1¶­Ò»Æ½1ÕÅÓ±1¡÷ÕÅÄþ1Áּ̺ì1ÀîÎÞÒõ1
1ºÓÄÏÊ¡ÂåÑôÕý¹ÇÒ½Ôº(ºÓÄÏÊ¡¹Ç¿ÆÒ½Ôº)÷ŹؽÚÍâÎå¿Æ(ºÓÄÏ ÂåÑô,471002)
Author(s):
YUAN Qiang1DONG Yiping1ZHANG Ying1¡÷ZHANG Ning1LIN Jihong1LI Wuyin1
1Luoyang Orthopedic-Traumatological Hospital(Orthopedics Hospital of Henan Province), Luoyang 471002, Henan China.
¹Ø¼ü´Ê:
¹É¹ÇÍ·»µËÀ »µËÀÃæ»ý ¸»ÑªÐ¡°åѪ½¬ ¹É¹ÇÍ·»µËÀÓú½ºÄÒ ÌÛÍ´ ¹¦ÄÜ
Keywords:
osteonecrosis of the femoral head necrosis area platelet-rich plasma Gugutou Huaisiyu capsules pain function
·ÖÀàºÅ:
R681.8
DOI:
10.20085/j.cnki.issn1005-0205.230307
ÎÄÏ×±êÖ¾Âë:
A
ÕªÒª:
Ä¿µÄ:±È½Ï·ÖÎö¸»ÑªÐ¡°åѪ½¬ÁªºÏ¹É¹ÇÍ·»µËÀÓú½ºÄÒÖÎÁƲ»Í¬Ãæ»ý¹É¹ÇÍ·»µËÀµÄÁÆЧ¡£·½·¨:»Ø¹ËÐÔ·ÖÎö 2018Äê8ÔÂÖÁ2020Äê6Ô½ÓÊܸ»ÑªÐ¡°åѪ½¬ÁªºÏ¹É¹ÇÍ·»µËÀÓú½ºÄÒÖÎÁƵÄ80Àý(109÷Å)ARCO¢òÆÚ·Ç´´ÉËÐԹɹÇÍ·»µËÀ»¼ÕߵIJ¡Àý×ÊÁÏ,ÔËÓùɹÇÍ·»µËÀÃæ»ýͳ¼ÆÈí¼þÆÀ¹ÀËùÓл¼÷ÅÖÎÁÆÇ°µÄ»µËÀÃæ»ý±ÈÀý,²¢½«Æä·ÖΪÁ½×é,»µËÀÃæ»ý±ÈÀý¡Ü30%×é39Àý(54÷Å),»µËÀÃæ»ý±ÈÀý>30%×é41Àý(55÷Å); ±È½ÏÁ½×黼ÕßÖÎÁƺó6¸öÔ¼°Ä©´ÎËæ·ÃʱµÄÁÙ´²ÁÆЧÓëÓ°Ïñ×ÊÁÏ¡£½á¹û:Á½×黼ÕßËæ·Ãʱ¼ä¾ùΪ18¸öÔÂÒÔÉÏ,ƽ¾ùΪ(25.48±8.48)¸öÔ¡£ÖÎÁƺó6¸öÔÂʱ,»µËÀÃæ»ý±ÈÀý¡Ü30%×éÔÚÌÛÍ´ÊÓ¾õÄ£ÄâÁ¿±í(VAS)ÆÀ·Ö¡¢Harris ÆÀ·Ö¼°÷ÅÉìÇü·¶Î§µÈ·½ÃæÏÔÖøÓÅÓÚ»µËÀÃæ»ý±ÈÀý>30%×é,²îÒìÓÐͳ¼ÆѧÒâÒå(P<0.05); Ä©´ÎËæ·Ãʱ,»µËÀÃæ»ý±ÈÀý¡Ü30%×éVAS ÆÀ·Ö¡¢Harris ÆÀ·ÖÒÔ¼°÷ÅÉ췶Χ¡¢ÄÚÍâÐý·¶Î§¡¢ÄÚÊÕÍâÕ¹·¶Î§¾ùÏÔÖøÓÅÓÚ»µËÀÃæ»ý±ÈÀý>30%×é,²îÒìÓÐͳ¼ÆѧÒâÒå(P<0.05)¡£Ä©´ÎËæ·ÃʱÁ½×éµÄÓ°ÏñÆÀ¼¶¡¢¹ÇËèË®Ö×·Ö¼¶²îÒì¾ùÓÐͳ¼ÆѧÒâÒå(P<0.05); Ëæ·Ã¹ý³ÌÖÐËùÓв¡Àý¾ùδ³öÏÖÑÏÖز»Á¼·´Ó¦¡£½áÂÛ:¸»ÑªÐ¡°åѪ½¬ÁªºÏ¹É¹ÇÍ·»µËÀÓú½ºÄÒ¿ÉÃ÷ÏÔ¸ÄÉÆARCO¢òÆڹɹÇÍ·»µËÀµÄÖ¢×´,¸ÄÉÆÆä÷Źؽڹ¦ÄÜ,¶ÔСÃæ»ý»µËÀÕß(»µËÀÃæ»ý±ÈÀý¡Ü30%)Ч¹û¸üÓÅ¡£
Abstract:
Objective:To compare and analyze the efficacy of platelet-rich plasma combined with Gugutou Huaisiyu capsules on the treatment of osteonecrosis of the femoral head with different lesion areas.Methods:The clinical data of 80 patients(109 hips)with early and middle stage non-traumatic osteonecrosis of the femoral head treated with platelet-rich plasma combined with Gugutou Huaisiyu capsules from August 2018 to June 2020 were analyzed retrospectively. The area ratio of necrosis of all hips before treatment was evaluated by femoral head necrosis area statistical software, and the patients were divided into two groups: 39 cases(54 hips)in area ratio of necrosis ¡Ü30% group, 41 cases(55 hips)in area ratio of necrosis >30% group. The clinical efficacy and imaging data of the two groups were compared 6 months after treatment and at the last follow-up.Results:The follow-up time of patients in both groups was more than 18 months, with an average of(25.48 ±8.48)months. At 6 months after treatment, the visual analogue scale(VAS)score, Harris score and range of motion(ROM)of hip extension and flexion in the area ratio of necrosis ¡Ü30% group were significantly better than those in the area ratio of necrosis >30% group(P<0.05). At the last follow-up, the VAS score, Harris score, hip extension ROM, internal and external rotation ROM and adduction and abduction ROM in the area ratio of necrosis ¡Ü30% group were significantly better than those in the area ratio of necrosis >30% group(P>0.05). In terms of imaging, there were significant differences in imaging rating and bone marrow edema grade between the two groups during the last follow-up, and there were no serious adverse reactions in all cases during the follow-up.Conclusion:Platelet-rich plasma combined with Gugutou Huaisiyu capsules can significantly improve the symptoms of early and middle osteonecrosis of the femoral head, improve the function of the hip joint, and has a better efficacy on small area(area ratio of necrosis ¡Ü30%)necrotic deaths.

²Î¿¼ÎÄÏ×/References:

[1] MOYA-ANGELER J,GIANAKOS A L,VILLA J C,et al.Current concepts on osteonecrosis of the femoral head[J].World J Orthop,2015,6(8):590-601.
[2] MWALE F,WANG H,JOHNSON A J,et al.Abnormal vascular endothelial growth factor expression in mesenchymal stem cells from both osteonecrotic and osteoarthritic hips[J].Bull NYU Hosp Jt Dis,2011,69(Suppl 1):S56-S61.
[3] XU H H,LI S M,FANG L,et al.Platelet-rich plasma promotes bone formation,restrains adipogenesis and accelerates vascularization to relieve steroids-induced osteonecrosis of the femoral head[J].Platelets,2021,32(7):950-959.
[4] LUAN S,LIU C,LIN C,et al.Platelet-rich plasma for the treatment of adolescent late-stage femoral head necrosis:a case report[J].Regen Med,2020,15(9):2067-2073.
[5] HAN J,GAO F,LI Y,et al.The use of platelet-rich plasma for the treatment of osteonecrosis of the femoral head:a systematic review[J].Biomed Res Int,2020:2642439.
[6] ÕÅÓ±,ÕÅÀÙÀÙ,ËïÈð²¨,µÈ.²¹Éö»îѪ·¨¶ÔÈ˹ÇËè¼ä³äÖʸÉϸ°û³É¹ÇÄÜÁ¦µÄÓ°Ïì¼°miR-93-5p¶ÔÆäµÄÒÖÖÆ×÷ÓÃ[J].ÖлªÖÐÒ½Ò©ÔÓÖ¾,2018,33(2):667-671.
[7] ÖлªÒ½Ñ§»á¹Ç¿Æѧ·Ö»á¹Ø½ÚÍâ¿Æѧ×é.¹É¹ÇÍ·»µËÀÁÙ´²ÕïÁƹ淶[J].Öйú½ÃÐÎÍâ¿ÆÔÓÖ¾,2016,24(1):49-54.
[8] YOON B H,MONT M A,KOO K H,et al.The 2019 revised version of association research circulation osseous staging system of osteonecrosis of the femoral head[J].J Arthroplasty,2020,35(4):933-940.
[9] CHEN X,TAN X,GAO S,et al.Sartorius muscle-pedicle bone graft for osteonecrosis of the femoral head[J].Int Orthop,2016,40(7):1417-1425.
[10] ÕÔÅàÈÙ,ׯÆæÐÂ,ÇÇÈð»ª,µÈ.¹É¹ÇͷȱѪ»µËÀ¹ÇËèË®Ö×µÄMRIÑо¿[J].ʵÓ÷ÅÉäѧÔÓÖ¾,2006(7):835-837.
[11] LIU L H,ZHANG Q Y,SUN W,et al.Corticosteroid-induced osteonecrosis of the femoral head:detection,diagnosis,and treatment in earlier stages[J].Chin Med J,2017,130(21):2601-2607.
[12] ATIK O ÿðþ ‰C .Overuse and abuse of cortisone[J].Eklem Hastalik Cerrahisi,2017,28(1):1.
[13] PIJNENBURG L,FELTEN R,JAVIER R M.A review of avascular necrosis of the hip and beyond[J].Rev Med Interne,2020,41(1):27-36.
[14] GRASSI M,SALARI P,MASSETTI D,et al.Treatment of avascular osteonecrosis of femoral head by core decompression and platelet-rich plasma:a prospective not controlled study[J].Int Orthop,2020,44(7):1287-1294.
[15] HONG Y C,ZHONG H M,LIN T,et al.Comparison of core decompression and conservative treatment for avascular necrosis of femoral head at early stage:a meta-analysis[J].Int J Clin Exp Med,2015,8(4):5207-5216.
[16] SADILE F,BERNASCONI A,RUSSO S,et al.Core decompression versus other joint preserving treatments for osteonecrosis of the femoral head:a meta-analysis[J].Br Med Bull,2016,118(1):33-49.
[17] STULBERG B N,DAVIS A W,BAUER T W,et al.Osteonecrosis of the femoral head:a prospective randomized treatment protocol[J].Clin Orthop Relat Res,1991,268(2):140-151.
[18] TABATABAEE R M,SABERI S,PARVIZI J,et al.Combining concentrated autologous bone marrow stem cells injection with core decompression improves outcome for patients with early-stage osteonecrosis of the femoral head:a comparative study[J].J Arthroplasty,2015,30(9 Suppl):11-15.
[19] YOON B H,LEE Y K,KIM K C,et al.No differences in the efficacy among various core decompression modalities and non-operative treatment:a network meta-analysis[J].Int Orthop,2018,42(12):2737-2743.
[20] ALSOUSOU J,THOMPSON M,HULLEY P,et al.The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery:a review of the literature[J].J Bone Joint Surg Br,2009,91(8):987-996.
[21] EVERTS P,ONISHI K,JAYARAM P,et al.Platelet-rich plasma:new performance understandings and therapeutic considerations in 2020[J].Int J Mol Sci,2020,21(20):7794.
[22] TONG S,YIN J,LIU J.Platelet-rich plasma has beneficial effects in mice with osteonecrosis of the femoral head by promoting angiogenesis[J].Exp Ther Med,2018,15(2):1781-1788.
[23] GIUSTI I,D'ASCENZO S,MACCHIARELLI G,et al.In vitro evidence supporting applications of platelet derivatives in regenerative medicine[J].Blood Transfus,2020,18(2):117-129.
[24] YUAN T,GUO S C,HAN P,et al.Applications of leukocyte and platelet-rich plasma(L-PRP)in trauma surgery[J].Curr Pharm Biotechnol,2012,13(7):1173-1184.
[25] LUAN S,WANG S,LIN C,et al.Comparisons of ultrasound-guided platelet-rich plasma intra-articular injection and extracorporeal shock wave therapy in treating ARCO ¢ñ-¢ó symptomatic non-traumatic femoral head necrosis:a randomized controlled clinical trial[J].J Pain Res,2022,15:341-354.
[26] MAMMADOVA-BACH E,MAULER M,BRAUN A,et al.Autocrine and paracrine regulatory functions of platelet serotonin[J].Platelets,2018,29(6):541-548.
[27] FILARDO G,KON E,ROFFI A,et al.Platelet-rich plasma:why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration[J].Knee Surg Sports Traumatol Arthrosc,2015,23(9):2459-2474.
[28] AGGARWAL A K,POORNALINGAM K,JAIN A,et al.Combining platelet-rich plasma instillation with core decompression improves functional outcome and delays progression in early-stage avascular necrosis of femoral head:a 4.5- to 6-year prospective randomized comparative study[J].J Arthroplasty,2021,36(1):54-61.
[29] STEPPACHER S D,SEDLMAYER R,TANNAST M,et al.Surgical hip dislocation with femoral osteotomy and bone grafting prevents head collapse in hips with advanced necrosis[J].Hip Int,2020,30(4):398-406.
[30] ËïÄ«Ô¨,Ñî¹âÒ«,ÕÅÀÙÀÙ,µÈ.¹É¹ÇÍ·»µËÀÓú½ºÄÒÁªºÏÍ·¾±²¿¿ª´°´òѹֲ¹ÇÖÎÁÆ·Ç´´ÉËÐԹɹÇÍ·»µËÀµÄÁÙ´²ÁÆЧ¹Û²ì[J].ÖйúÖÐÒ½¹ÇÉË¿ÆÔÓÖ¾,2022,30(6):42-47.
[31] ÕÅÑ©,Ðì±ò,ÁõÓÖÎÄ,µÈ.»ùÓÚÍøÂçÒ©Àíѧ·½·¨·ÖÎö¹É¹ÇÍ·»µËÀÓú½ºÄÒÖÎÁƹɹÇÍ·»µËÀµÄDZÔڰе㼰×÷ÓûúÖÆ[J].ÖÐÒ½Õý¹Ç,2022,34(1):1-7.

±¸×¢/Memo

±¸×¢/Memo:
»ù½ðÏîÄ¿:¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿(81774348,81874477)
ºÓÄÏÊ¡ÖصãÑз¢ÓëÍƹãרÏî(¿Æ¼¼¹¥¹Ø)(212102310365)
ºÓÄÏÊ¡ÖÐÒ½Ò©¿ÆѧÑо¿×¨Ïî¿ÎÌâ(20-21ZY2247)
¡÷ͨÐÅ×÷Õß E-mail:hhxi2021@163.cm
¸üÐÂÈÕÆÚ/Last Update: 2023-03-10